{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:40:31Z","timestamp":1791949231056,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:00:00Z","timestamp":1469491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11912-016-0532-y","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:32:12Z","timestamp":1469493132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and\/or Radiation Exposure"],"prefix":"10.1007","volume":"18","author":[{"given":"Vinisha","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Vorobiof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"key":"532_CR1","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1200\/JCO.2005.02.5841","volume":"23","author":"JJ Doyle","year":"2005","unstructured":"Doyle JJ, Neugut AI, Jacobson JS, Grann VR, Hershman DL. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol. 2005;23:8597\u2013605.","journal-title":"J Clin Oncol"},{"key":"532_CR2","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","volume":"53","author":"ET Yeh","year":"2009","unstructured":"Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009;53:2231\u201347.","journal-title":"J Am Coll Cardiol"},{"key":"532_CR3","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/CIRCULATIONAHA.112.100560","volume":"126","author":"MG Khouri","year":"2012","unstructured":"Khouri MG, Douglas PS, Mackey JR, et al. Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues. Circulation. 2012;126:2749\u201363.","journal-title":"Circulation"},{"key":"532_CR4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrcardio.2010.121","volume":"7","author":"MS Ewer","year":"2010","unstructured":"Ewer MS, Ewer SM. Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Nat Rev Cardiol. 2010;7:564\u201375.","journal-title":"Nat Rev Cardiol"},{"key":"532_CR5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/157340311799960645","volume":"7","author":"M Volkova","year":"2011","unstructured":"Volkova M, Russell 3rd R. Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev. 2011;7:214\u201320.","journal-title":"Curr Cardiol Rev"},{"issue":"Supplement 2","key":"532_CR6","first-page":"ii127","volume":"16","author":"F Venneri LC","year":"2015","unstructured":"Venneri LC F, Manivarmane R, Pareek N, Baksi J, Rosen S, Senior R, et al. Subclinical myocardial dysfunction in cancer patients: is there a direct effect of tumour growth? Eur Heart J Cardiovasc Imag Abstracts Suppl. 2015;16(Supplement 2):ii127.","journal-title":"Eur Heart J Cardiovasc Imag Abstracts Suppl"},{"key":"532_CR7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","volume":"27","author":"JC Plana","year":"2014","unstructured":"Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014;27:911\u201339. Expert consensus which provides a detailed review of the imaging modalities in the evalution of cancer patients.","journal-title":"J Am Soc Echocardiogr"},{"key":"532_CR8","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale D, Colombo A, Bacchiani G, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131:1981\u20138.","journal-title":"Circulation"},{"key":"532_CR9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jama.2010.923","volume":"304","author":"RC Reulen","year":"2010","unstructured":"Reulen RC, Winter DL, Frobisher C, et al. Long-term cause-specific mortality among survivors of childhood cancer. JAMA. 2010;304:172\u20139.","journal-title":"JAMA"},{"key":"532_CR10","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1001\/jama.1991.03470120074036","volume":"266","author":"LJ Steinherz","year":"1991","unstructured":"Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA. 1991;266:1672\u20137.","journal-title":"JAMA"},{"key":"532_CR11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","volume":"342","author":"GM Felker","year":"2000","unstructured":"Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077\u201384.","journal-title":"N Engl J Med"},{"key":"532_CR12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM197902083000603","volume":"300","author":"J Alexander","year":"1979","unstructured":"Alexander J, Dainiak N, Berger HJ, et al. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med. 1979;300:278\u201383.","journal-title":"N Engl J Med"},{"key":"532_CR13","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0002-8703(83)90080-7","volume":"106","author":"BW Choi","year":"1983","unstructured":"Choi BW, Berger HJ, Schwartz PE, et al. Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance. Am Heart J. 1983;106:638\u201343.","journal-title":"Am Heart J"},{"key":"532_CR14","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0002-9343(87)90212-9","volume":"82","author":"RG Schwartz","year":"1987","unstructured":"Schwartz RG, McKenzie WB, Alexander J, et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med. 1987;82:1109\u201318.","journal-title":"Am J Med"},{"key":"532_CR15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1067\/mnc.2003.7","volume":"10","author":"I Mitani","year":"2003","unstructured":"Mitani I, Jain D, Joska TM, Burtness B, Zaret BL. Doxorubicin cardiotoxicity: prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era. J Nucl Cardiol. 2003;10:132\u20139.","journal-title":"J Nucl Cardiol"},{"issue":"Suppl 7","key":"532_CR16","doi-asserted-by":"crossref","first-page":"vii155","DOI":"10.1093\/annonc\/mds293","volume":"23","author":"G Curigliano","year":"2012","unstructured":"Curigliano G, Cardinale D, Suter T. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23 Suppl 7:vii155\u201366.","journal-title":"Ann Oncol"},{"key":"532_CR17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/0002-8703(83)90651-8","volume":"106","author":"JH McKillop","year":"1983","unstructured":"McKillop JH, Bristow MR, Goris ML, Billingham ME, Bockemuehl K. Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. Am Heart J. 1983;106:1048\u201356.","journal-title":"Am Heart J"},{"key":"532_CR18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12350-012-9512-2","volume":"19","author":"RS Jiji","year":"2012","unstructured":"Jiji RS, Kramer CM, Salerno M. Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs. J Nucl Cardiol. 2012;19:377\u201388.","journal-title":"J Nucl Cardiol"},{"key":"532_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/echo.12331","volume":"31","author":"PW Wood","year":"2014","unstructured":"Wood PW, Choy JB, Nanda NC, Becher H. Left ventricular ejection fraction and volumes: it depends on the imaging method. Echocardiography. 2014;31:87\u2013100.","journal-title":"Echocardiography"},{"key":"532_CR20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2009.01.005","volume":"53","author":"M Kurt","year":"2009","unstructured":"Kurt M, Shaikh KA, Peterson L, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol. 2009;53:802\u201310.","journal-title":"J Am Coll Cardiol"},{"key":"532_CR21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.echo.2007.01.010","volume":"20","author":"J Hung","year":"2007","unstructured":"Hung J, Lang R, Flachskampf F, et al. 3D echocardiography: a review of the current status and future directions. J Am Soc Echocardiogr. 2007;20:213\u201333.","journal-title":"J Am Soc Echocardiogr"},{"key":"532_CR22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/eurheartj\/ehi666","volume":"27","author":"LD Jacobs","year":"2006","unstructured":"Jacobs LD, Salgo IS, Goonewardena S, et al. Rapid online quantification of left ventricular volume from real-time three-dimensional echocardiographic data. Eur Heart J. 2006;27:460\u20138.","journal-title":"Eur Heart J"},{"key":"532_CR23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jcmg.2008.02.009","volume":"1","author":"V Mor-Avi","year":"2008","unstructured":"Mor-Avi V, Jenkins C, Kuhl HP, et al. Real-time 3-dimensional echocardiographic quantification of left ventricular volumes: multicenter study for validation with magnetic resonance imaging and investigation of sources of error. JACC Cardiovasc Imag. 2008;1:413\u201323.","journal-title":"JACC Cardiovasc Imag"},{"key":"532_CR24","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.amjcard.2014.03.019","volume":"113","author":"K Ylanen","year":"2014","unstructured":"Ylanen K, Eerola A, Vettenranta K, Poutanen T. Three-dimensional echocardiography and cardiac magnetic resonance imaging in the screening of long-term survivors of childhood cancer after cardiotoxic therapy. Am J Cardiol. 2014;113:1886\u201392.","journal-title":"Am J Cardiol"},{"key":"532_CR25","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","volume":"63","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63:2751\u201368.","journal-title":"J Am Coll Cardiol"},{"key":"532_CR26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","volume":"55","author":"D Cardinale","year":"2010","unstructured":"Cardinale D, Colombo A, Lamantia G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55:213\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"532_CR27","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1200\/JCO.2009.27.3615","volume":"28","author":"D Cardinale","year":"2010","unstructured":"Cardinale D, Colombo A, Torrisi R, et al. Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation. J Clin Oncol. 2010;28:3910\u20136.","journal-title":"J Clin Oncol"},{"key":"532_CR28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.echo.2012.04.007","volume":"25","author":"JT Poterucha","year":"2012","unstructured":"Poterucha JT, Kutty S, Lindquist RK, Li L, Eidem BW. Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction. J Am Soc Echocardiogr. 2012;25:733\u201340.","journal-title":"J Am Soc Echocardiogr"},{"key":"532_CR29","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.echo.2007.04.007","volume":"20","author":"J Ganame","year":"2007","unstructured":"Ganame J, Claus P, Uyttebroeck A, et al. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients. J Am Soc Echocardiogr. 2007;20:1351\u20138.","journal-title":"J Am Soc Echocardiogr"},{"key":"532_CR30","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.echo.2008.10.005","volume":"21","author":"R Jurcut","year":"2008","unstructured":"Jurcut R, Wildiers H, Ganame J, et al. Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer. J Am Soc Echocardiogr. 2008;21:1283\u20139.","journal-title":"J Am Soc Echocardiogr"},{"key":"532_CR31","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/heartjnl-2015-307848","volume":"101","author":"N Pavo","year":"2015","unstructured":"Pavo N, Raderer M, Hulsmann M, et al. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality. Heart. 2015;101:1874\u201380.","journal-title":"Heart"},{"key":"532_CR32","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jacc.2012.01.005","volume":"59","author":"PS Douglas","year":"2012","unstructured":"Douglas PS, Carr JJ, Cerqueira MD, et al. Developing an action plan for patient radiation safety in adult cardiovascular medicine: proceedings from the Duke University Clinical Research Institute\/American College of Cardiology Foundation\/American Heart Association Think Tank held on February 28, 2011. J Am Coll Cardiol. 2012;59:1833\u201347.","journal-title":"J Am Coll Cardiol"},{"key":"532_CR33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijcard.2005.07.029","volume":"111","author":"M Civelli","year":"2006","unstructured":"Civelli M, Cardinale D, Martinoni A, et al. Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity. Int J Cardiol. 2006;111:120\u20136.","journal-title":"Int J Cardiol"},{"key":"532_CR34","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0735-1097(92)90497-B","volume":"19","author":"SE Klewer","year":"1992","unstructured":"Klewer SE, Goldberg SJ, Donnerstein RL, Berg RA, Hutter Jr JJ. Dobutamine stress echocardiography: a sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. J Am Coll Cardiol. 1992;19:394\u2013401.","journal-title":"J Am Coll Cardiol"},{"key":"532_CR35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/01.CIR.82.1.154","volume":"82","author":"GB Cranney","year":"1990","unstructured":"Cranney GB, Lotan CS, Dean L, Baxley W, Bouchard A, Pohost GM. Left ventricular volume measurement using cardiac axis nuclear magnetic resonance imaging. Validation by calibrated ventricular angiography. Circulation. 1990;82:154\u201363.","journal-title":"Circulation"},{"key":"532_CR36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/COC.0b013e31829e19be","volume":"38","author":"MA Lunning","year":"2015","unstructured":"Lunning MA, Kutty S, Rome ET, et al. Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy. Am J Clin Oncol. 2015;38:377\u201381.","journal-title":"Am J Clin Oncol"},{"key":"532_CR37","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","volume":"6","author":"BC Drafts","year":"2013","unstructured":"Drafts BC, Twomley KM, D\u2019Agostino Jr R, et al. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imag. 2013;6:877\u201385.","journal-title":"JACC Cardiovasc Imag"},{"key":"532_CR38","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jacc.2008.06.049","volume":"52","author":"L Iles","year":"2008","unstructured":"Iles L, Pfluger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52:1574\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"532_CR39","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacc.2006.07.003","volume":"48","author":"RC Hendel","year":"2006","unstructured":"Hendel RC, Patel MR, Kramer CM. ACCF\/ACR\/SCCT\/SCMR\/ASNC\/NASCI\/SCAI\/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006;48:1475\u201397.","journal-title":"J Am Coll Cardiol"},{"key":"532_CR40","first-page":"396","volume":"17","author":"NM Meyersohn","year":"2015","unstructured":"Meyersohn NM, Pursnani A, Neilan TG. Detection of cardiac toxicity due to cancer treatment: role of cardiac MRI. Curr Treat Options Cardiovasc Med. 2015;17:396.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"532_CR41","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2011.40.3584","volume":"30","author":"GT Armstrong","year":"2012","unstructured":"Armstrong GT, Plana JC, Zhang N, et al. Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging. J Clin Oncol. 2012;30:2876\u201384.","journal-title":"J Clin Oncol"},{"key":"532_CR42","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0002-9149(97)89179-5","volume":"77","author":"N Royen van","year":"1996","unstructured":"van Royen N, Jaffe CC, Krumholz HM, et al. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol. 1996;77:843\u201350.","journal-title":"Am J Cardiol"},{"key":"532_CR43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2796.2001.00820.x","volume":"249","author":"T Nousiainen","year":"2001","unstructured":"Nousiainen T, Vanninen E, Jantunen E, et al. Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy. J Intern Med. 2001;249:297\u2013303.","journal-title":"J Intern Med"},{"key":"532_CR44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/08880010500313603","volume":"23","author":"F Corapcioglu","year":"2006","unstructured":"Corapcioglu F, Sarper N, Berk F, Sahin T, Zengin E, Demir H. Evaluation of anthracycline-induced early left ventricular dysfunction in children with cancer: a comparative study with echocardiography and multigated radionuclide angiography. Pediatr Hematol Oncol. 2006;23:71\u201380.","journal-title":"Pediatr Hematol Oncol"},{"key":"532_CR45","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1200\/JCO.2009.26.7294","volume":"28","author":"J Walker","year":"2010","unstructured":"Walker J, Bhullar N, Fallah-Rad N, et al. Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging. J Clin Oncol. 2010;28:3429\u201336.","journal-title":"J Clin Oncol"},{"key":"532_CR46","doi-asserted-by":"crossref","first-page":"268058","DOI":"10.4061\/2011\/268058","volume":"2011","author":"IN Daher","year":"2011","unstructured":"Daher IN, Banchs J, Yusuf SW, Mouhayar E, Durand JB, Gladish G. Impact of cardiac computed tomographic angiography findings on planning of cancer therapy in patients with concomitant structural heart disease. Cardiol Res Pract. 2011;2011:268058.","journal-title":"Cardiol Res Pract"},{"key":"532_CR47","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1200\/JCO.2009.25.2627","volume":"28","author":"S Kupeli","year":"2010","unstructured":"Kupeli S, Hazirolan T, Varan A, et al. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin\u2019s lymphoma. J Clin Oncol. 2010;28:1025\u201330.","journal-title":"J Clin Oncol"},{"key":"532_CR48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjcard.2009.09.005","volume":"105","author":"R Andersen","year":"2010","unstructured":"Andersen R, Wethal T, Gunther A, et al. Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin\u2019s lymphoma. Am J Cardiol. 2010;105:149\u201352.","journal-title":"Am J Cardiol"},{"key":"532_CR49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0167-8140(99)00026-2","volume":"51","author":"JG Reinders","year":"1999","unstructured":"Reinders JG, Heijmen BJ, Olofsen-van Acht MJ, van Putten WL, Levendag PC. Ischemic heart disease after mantlefield irradiation for Hodgkin\u2019s disease in long-term follow-up. Radiother Oncol. 1999;51:35\u201342.","journal-title":"Radiother Oncol"},{"key":"532_CR50","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ijrobp.2011.08.012","volume":"83","author":"ME Mast","year":"2012","unstructured":"Mast ME, Heijenbrok MW, Petoukhova AL, Scholten AN, Schreur JH, Struikmans H. Preradiotherapy calcium scores of the coronary arteries in a cohort of women with early-stage breast cancer: a comparison with a cohort of healthy women. Int J Radiat Oncol Biol Phys. 2012;83:853\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"532_CR51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-9966-31-13","volume":"31","author":"L Roziakova","year":"2012","unstructured":"Roziakova L, Bojtarova E, Mistrik M, et al. Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation. J Exp Clin Cancer Res. 2012;31:13.","journal-title":"J Exp Clin Cancer Res"},{"key":"532_CR52","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","volume":"57","author":"N Fallah-Rad","year":"2011","unstructured":"Fallah-Rad N, Walker JR, Wassef A, et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol. 2011;57:2263\u201370.","journal-title":"J Am Coll Cardiol"},{"key":"532_CR53","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ejhf.8","volume":"16","author":"Y Kang","year":"2014","unstructured":"Kang Y, Xu X, Cheng L, et al. Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy. Eur J Heart Fail. 2014;16:300\u20138.","journal-title":"Eur J Heart Fail"},{"key":"532_CR54","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/pbc.25651","volume":"62","author":"A Ramjaun","year":"2015","unstructured":"Ramjaun A, AlDuhaiby E, Ahmed S, et al. Echocardiographic detection of cardiac dysfunction in childhood cancer survivors: how long is screening required? Pediatr Blood Cancer. 2015;62:2197\u2013203.","journal-title":"Pediatr Blood Cancer"},{"key":"532_CR55","volume-title":"Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers, version 3.0","author":"Children\u2019s Oncology Group","year":"2008","unstructured":"Children\u2019s Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers, version 3.0. Arcadia: Children\u2019s Oncology Group; 2008."},{"key":"532_CR56","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S1470-2045(14)70409-7","volume":"16","author":"SH Armenian","year":"2015","unstructured":"Armenian SH, Hudson MM, Mulder RL, et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015;16:e123\u201336.","journal-title":"Lancet Oncol"},{"key":"532_CR57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.seminoncol.2013.01.005","volume":"40","author":"JR Carver","year":"2013","unstructured":"Carver JR, Szalda D, Ky B. Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance. Semin Oncol. 2013;40:229\u201338. This article summarizes screening strategies for cancer patients as well as surveillance strategies for long-term cancer survivors.","journal-title":"Semin Oncol"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-016-0532-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-016-0532-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-016-0532-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T13:50:16Z","timestamp":1568209816000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-016-0532-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["532"],"URL":"https:\/\/doi.org\/10.1007\/s11912-016-0532-y","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]},"article-number":"52"}}